With 40 million adults affected yearly, anxiety is the most prevalent mental health issue in the U.S., affecting 18.1% of the population. People who struggle with Anxiety disorders frequently experience depression as well. Anxiety disorders coexist with depression in 50% of patients.
Six million individuals experience panic disorder, 15 million from a social Anxiety disorder, and 7.7 million adults each year experience post-traumatic stress disorder (PTSD).
According to the Anxiety and Depression Association of America (ADAA), 264 million people worldwide suffer from depression on some level. 17.3 million persons over 18 years—or 6.7 percent of all adults in the nation—had at least one major depressive episode in the previous year in 2017.
When treating mental health conditions like anxiety or depression, Klonopin is a reasonable choice as it has an intermediate onset of effect. It's crucial to comprehend how the drug functions and how it will fit into your treatment strategy. Let us see how Klonopin treats anxiety in more detail.
In 1975, the U.S. Food and Drug Administration (FDA) approved Klonopin as a generic benzodiazepine medication for anxiety and depression. Klonopin is a sedative-hypnotic medication belonging to the larger class of CNS depressants.
The most common conditions for which Klonopin is prescribed are epilepsy, panic disorder, and manic episodes. It also appears to be beneficial in treating antipsychotic drug-induced akathisia.
It is a long-acting benzodiazepine that occasionally aids in treating persistent, bothersome parasomnias in children. The use of Klonopin in children younger than 18 years of age is not approved. You can get a Klonopin prescription online from a doctor for buying this drug, because it is compulsory to have a prescription for a controlled drug.
Klonopin is a long-acting benzodiazepine and has strong potency. It has GABA-A receptor agonist properties. By boosting serotonin production, it also exhibits serotonergic activity. It also has anxiolytic and anticonvulsant properties.
Seizure disorders: Its two main indications are acute treatment of non-convulsive status epilepticus and epilepsy (complex partial or absence seizures). Furthermore, it works very well in controlling minor motor seizures associated with childhood, including petit mal absences, Lennox Gastaut syndrome, and infantile spasms.
Patients with petit mal absence seizures who have not responded to succinimides can benefit from Klonopin. Additionally, Klonopin aids in the management of psychomotor, myoclonic, grand mal, and focal motor seizures. It is not, however, the first-line treatment for these conditions. Patients who are resistant to conventional treatment can utilize it.
Patients with panic disorders, with or without agoraphobia, benefit significantly from Klonopin. Due to the possibility of experiencing withdrawal symptoms and abuse, it effectively treats panic disorder. However, due to its longer half-life compared to other benzodiazepines, it is also less likely to result in rebound anxiety upon cessation. Clinicians also use it to treat acute panic attacks.
Used as monotherapy or adjunctive therapy to treat
It also appears to be effective in relieving antipsychotic drug-induced akathisia. Children with persistent, upsetting parasomnias may benefit from Klonopin treatment.
Klonopin is a sedative-hypnotic drug under the general class of CNS depressants. A benzodiazepine with a lengthy half-life, Klonopin is highly potent. It affects GABA-A receptors pharmacologically by functioning as a positive allosteric modulator.
Benzodiazepines (BZDs) reduce the excitability of neurons by increasing the frequency with which chloride channels open, thus facilitating GABA-A action.
Klonopin may help to treat numerous Anxiety disorders, such as Anxiety disorder, generalized Anxiety disorder, and panic disorder.
Anxiety causes symptoms like intense worry or panic, sweating, a racing heart, or physical manifestations. Other signs and symptoms can include irritation, restlessness, difficulty sleeping, and muscle tightness.
In a study, Wang SM evaluated the effectiveness and Safety of three different BZDs (alprazolam, Klonopin, and Lorazepam) in people with Anxiety disorders. It was a retrospective, multicenter trial.
The present study included a total of 180 patients who were over the age of 20. They met the requirements for the DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision) diagnosis of Anxiety disorder. The study participants had been taking only one type of antidepressant for over six weeks.
The patients received a prescription for one of the three oral BZDs (alprazolam, Klonopin, or Lorazepam) for six weeks. Similar to earlier trials, all three BZDs significantly reduced anxiety symptoms compared to the baseline, but there were no significant differences between the drugs.
There were no severe events, and all the side effects were mild. Compared to the alprazolam and Lorazepam groups, the incidence of adverse events was considerably lower overall in the Klonopin group.
The results show that Klonopin may be a suitable medication for treating Anxiety disorder in patients using concomitant antidepressants because it requires a lower dose and offers a more favorable side effect profile than Lorazepam or alprazolam. Additionally, the absence of drug interactions between Klonopin and antidepressants may be a significant factor because all of the subjects were on antidepressants concurrently.
It is common to treat anxiety using benzodiazepines, such as Klonopin, because they reduce electrical activity in the brain. There is an immediate effect on social Anxiety symptoms with Klonopin, but the medication's other potential benefits may take longer to manifest.
Although the exact mechanism by which Klonopin lessens anxiety is unknown, it is believed to be connected to gamma-aminobutyric acid (GABA) activation. By attaching to GABA receptors, benzodiazepines calm the brain.
The efficacy of Klonopin in long-term use has not been thoroughly examined in controlled clinical trials. If a doctor decides to give a patient Klonopin for an extended period, they should periodically reevaluate the drug's potential long-term benefits. Long-term use of Klonopin may result in tolerance, dependence, and withdrawal symptoms if stopped abruptly.
An optimal dose is the one that produces the desired benefit with minor side effects. The strength of the medication determines how much of it you should take. Additionally, the medical condition for which you are utilizing the drug affects the number of doses you take each day, the interval between doses, and the duration of treatment.
These are common with most drugs. These are unwanted effects that occur after taking the medication. The likelihood of experiencing Klonopin side effects increases with the dose. Thus the more the drug a person takes, the greater their risk. Most minor side effects go away after a few days or weeks.
Loss of consciousness
The trouble with coordination and walking
Swelling of the face, throat, and eyes
Changes in sex drive or sexual performance
Problems with sleep or insomnia
Pain in muscles or joints
Sinus or respiratory problems
Klonopin is a potentially habit-forming benzodiazepine. Once someone becomes dependent on the drug, their brain can no longer produce emotions of tranquility and relaxation.
A Klonopin addiction may show the following symptoms:
People might require higher doses of the medication if they become more tolerant to provide the same effects they once did with lower ones. This is when Klonopin addiction begins. Following this, people start taking more than the prescribed amount to get high.
Klonopin withdrawal symptoms have been reported after abruptly stopping the drug. These symptoms are comparable to those associated with alcohol and barbiturates. Patients who took large doses over an extended period experienced severe withdrawal symptoms.
Following abrupt discontinuation of benzodiazepines administered continuously at therapeutic levels for several months, lesser withdrawal symptoms (such as dysphoria and sleeplessness) have typically been recorded. Thus, sudden withdrawal after prolonged therapy should generally be avoided and follow a gradual dosage tapering schedule.
Your doctor must monitor your progress at routine appointments to ensure the medication works as intended and allows for dose adjustments. Precautions are, therefore, required for the proper use of the drugs.
The effects of a Klonopin overdose are rarely lethal. Research indicated that for every million prescriptions for benzodiazepines, 3 to 7.9 deaths take place.
Signs and symptoms of an overdose
Call your doctor or get emergency help if you think anyone may have overdosed on the drug Klonopin (Klonopin).
The course of treatment for overdose entails immediate gastrointestinal lavage, general supportive measures, and monitoring of breathing, pulse, and blood pressure. Maintain adequate airway while intravenous fluids are delivered.
Levarterenol or metaraminol can be used to treat hypotension. Dialysis has no known benefits.
When a benzodiazepine overdose is known or suspected, flumazenil, a selective benzodiazepine-receptor antagonist, may be administered to wholly or partially reverse the sedative effects of benzodiazepines.
Drug interactions might change how your medications work or increase your chance of experiencing severe adverse effects. Never start, stop, or modify the dosage of any medicines without your doctor's approval.
Interactions of Klonopin
Klonopin is a benzodiazepine that may be used to relieve anxiety. It is soothing by affecting the brain's electrical and chemical activity. Even though Klonopin and other BZDs have side effects, including the risk of addiction, cognitive decline, and falls, their inappropriate long-term usage continues.
Consult your general practitioner if you have any drug-related questions or concerns. Never discontinue taking Klonopin without consulting your physician. If you stop taking the medication abruptly after long-term use, you can experience life-threatening withdrawal symptoms.
Does Wellbutrin Cause Weight Loss Or Weight Gain?
Irfana Parveen 19 September 2021
Wellbutrin Vs Lexapro: Which Is Best For Anxiety?
Irfana Parveen 19 September 2021
Anxiety & Depression
Over The Counter Anxiety Medications: Any Option?
Irfana Parveen 19 September 2021